Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V3OY
|
||||
Former ID |
DIB018428
|
||||
Drug Name |
[3H]U69593
|
||||
Synonyms |
[3H]-U69593
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C22H32N2O2
|
||||
InChI |
InChI=1S/C22H32N2O2/c1-23(21(25)16-18-8-3-2-4-9-18)19-10-12-22(11-7-15-26-22)17-20(19)24-13-5-6-14-24/h2-4,8-9,19-20H,5-7,10-17H2,1H3/t19-,20-,22-/m0/s1
|
||||
InChIKey |
PGZRDDYTKFZSFR-ONTIZHBOSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
841864, 7980860, 10233764, 26756545, 44434631, 48032743, 49689203, 50066063, 50093889, 53787917, 57338019, 76304920, 103177815, 103841744, 104373646, 117567761, 124892412, 128914721, 134349034, 135062519, 135651213, 135651293, 136946583, 142250937, 144205579, 144239943, 162224354, 163426066, 170466866, 172914645, 198966748, 227014322, 252451182
|
||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Agonist | [2] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Opioid prodynorphin pathway | |||||
Reactome | Peptide ligand-binding receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Peptide GPCRs | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1656). | ||||
REF 2 | [3H]U-69593 a highly selective ligand for the opioid kappa receptor. Eur J Pharmacol. 1985 Feb 26;109(2):281-4. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.